5 Key Takeaways
-
1
Generative AI has not significantly improved life sciences R&D due to limitations in early deployments and mismatched assumptions about scientific needs.
-
2
Trust in scientific outputs requires traceability and the ability to interrogate reasoning, which current AI tools often fail to provide.
-
3
Organizations are shifting from building custom AI systems to purchasing core capabilities while selectively building for specific workflows.
-
4
Fragmentation in scientific tools arises from differing accountability between R&D leaders and CIOs, leading to isolated solutions that lack integration.
-
5
The future of AI in R&D lies in systems taking responsibility for workflows, allowing scientists to focus on defining intent and evaluating outputs.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
